Viewing StudyNCT06207799



Ignite Creation Date: 2024-05-06 @ 7:58 PM
Last Modification Date: 2024-10-26 @ 3:18 PM
Study NCT ID: NCT06207799
Status: RECRUITING
Last Update Posted: 2024-07-12
First Post: 2024-01-05

Brief Title: Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-07-30
Start Date Type: ESTIMATED
Primary Completion Date: 2029-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2031-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-05
First Submit QC Date: January 5 2024
Study First Post Date: 2024-01-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-19
Last Update Post Date: 2024-07-12
Last Update Post Date Type: ACTUAL